Multicenter, retrospective comparison of implant survival, complications and cost between plate and screw and intramedullary nail fixation for metastatic lesions of the diaphyseal humerus.

Humerus cost fracture metastasis nail plate

Journal

Annals of joint
ISSN: 2415-6809
Titre abrégé: Ann Jt
Pays: China
ID NLM: 101711195

Informations de publication

Date de publication:
2022
Historique:
received: 15 07 2020
accepted: 22 02 2022
medline: 15 7 2022
pubmed: 15 7 2022
entrez: 26 3 2024
Statut: epublish

Résumé

The humerus is a common site of metastatic disease that can be fixated with either plate and screw or intramedullary nail (IMN) constructs. A multicenter retrospective comparison study was undertaken to compare implant survival, complication rate and cost between the two constructs. No prior studies have included a cost comparison. Databases of two academic practices were queried retrospectively to identify patients with metastases of the humerus. Inclusion criteria were a lesion in the proximal metaphysis to distal diaphysis and amenable to both implant options with available cost data. Follow-up was at least 6 months barring death or discharge to hospice sooner. Demographic, clinical and outcome data was recorded. Costs were estimated based on contract pricing. Operating room (OR) costs were estimated using per minute OR costs proposed by other investigators. One hundred and one humeri in 96 patients were included (72 plates and 29 nails). The most common malignancies were renal cell, myeloma and lung. Half presented with a displaced fracture. Demographics were similar in both groups. Lesions were larger in the plate group. Surgical times were longer in the plate group, 146 IMN of metastases of the humerus offers a faster, potentially more durable construct with lower blood loss, faster OR times and decreased cost of implantation.

Sections du résumé

Background UNASSIGNED
The humerus is a common site of metastatic disease that can be fixated with either plate and screw or intramedullary nail (IMN) constructs. A multicenter retrospective comparison study was undertaken to compare implant survival, complication rate and cost between the two constructs. No prior studies have included a cost comparison.
Methods UNASSIGNED
Databases of two academic practices were queried retrospectively to identify patients with metastases of the humerus. Inclusion criteria were a lesion in the proximal metaphysis to distal diaphysis and amenable to both implant options with available cost data. Follow-up was at least 6 months barring death or discharge to hospice sooner. Demographic, clinical and outcome data was recorded. Costs were estimated based on contract pricing. Operating room (OR) costs were estimated using per minute OR costs proposed by other investigators.
Results UNASSIGNED
One hundred and one humeri in 96 patients were included (72 plates and 29 nails). The most common malignancies were renal cell, myeloma and lung. Half presented with a displaced fracture. Demographics were similar in both groups. Lesions were larger in the plate group. Surgical times were longer in the plate group, 146
Conclusions UNASSIGNED
IMN of metastases of the humerus offers a faster, potentially more durable construct with lower blood loss, faster OR times and decreased cost of implantation.

Identifiants

pubmed: 38529133
doi: 10.21037/aoj-20-101
pii: aoj-07-24
pmc: PMC10929354
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24

Informations de copyright

2022 Annals of Joint. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://aoj.amegroups.com/article/view/10.21037/aoj-20-101/coif). The series “Bone Metastasis” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Auteurs

James P Norris (JP)

Vanderbilt University Medical Center, Nashville, TN, USA.
Spartanburg Regional Healthcare System, Spartanburg, SC, USA.

Jacob Shabason (J)

Perelman Center for Advanced Medicine, Philadelphia, PA, USA.

Jennifer L Halpern (JL)

Perelman Center for Advanced Medicine, Philadelphia, PA, USA.

Herbert S Schwartz (HS)

Perelman Center for Advanced Medicine, Philadelphia, PA, USA.

Kristy L Weber (KL)

Perelman Center for Advanced Medicine, Philadelphia, PA, USA.

Ginger E Holt (GE)

Perelman Center for Advanced Medicine, Philadelphia, PA, USA.

Robert J Wilson (RJ)

Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Baptist MD Anderson Cancer Center, Jacksonville, FL, USA.

Classifications MeSH